Bryan Jones - Feb 12, 2025 Form 3 Insider Report for Aardvark Therapeutics, Inc. (AARD)

Signature
/s/ Nelson Sun, as Attorney-in-Fact
Stock symbol
AARD
Transactions as of
Feb 12, 2025
Transactions value $
$0
Form type
3
Date filed
2/12/2025, 07:24 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AARD Stock Option (Right to Buy) Feb 12, 2025 Common Stock 5.9K $1.28 Direct F1
holding AARD Stock Option (Right to Buy) Feb 12, 2025 Common Stock 35.4K $3.05 Direct F2
holding AARD Stock Option (Right to Buy) Feb 12, 2025 Common Stock 35.4K $3.06 Direct F3
holding AARD Stock Option (Right to Buy) Feb 12, 2025 Common Stock 41.3K $4.24 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option is fully vested as of the date hereof.
F2 This option was exercisable at grant subject to a repurchase right in our favor that lapses as the option vests. 1/48th of the original number of shares subject to the option vested on October 1, 2021, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.
F3 This option was exercisable at grant subject to a repurchase right in our favor that lapses as the option vests. 1/48th of the original number of shares subject to the option vested on June 17, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.
F4 1/48th of the original number of shares subject to the option vested on July 27, 2024, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.

Remarks:

Exhibit 24 - Power of Attorney